KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) FCF Payout Ratio (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed FCF Payout Ratio for 17 consecutive years, with 0.79 as the latest value for Q4 2025.

  • On a quarterly basis, FCF Payout Ratio rose 162.33% to 0.79 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.39, a 12.6% increase, with the full-year FY2025 number at 0.39, up 12.6% from a year prior.
  • FCF Payout Ratio was 0.79 for Q4 2025 at Bristol Myers Squibb, up from 0.21 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 0.79 in Q4 2025 to a low of 0.0 in Q2 2021.
  • A 5-year average of 0.37 and a median of 0.32 in 2021 define the central range for FCF Payout Ratio.
  • Peak YoY movement for FCF Payout Ratio: crashed 98.8% in 2021, then surged 12086.9% in 2023.
  • Bristol Myers Squibb's FCF Payout Ratio stood at 0.29 in 2021, then soared by 31.53% to 0.39 in 2022, then dropped by 23.54% to 0.3 in 2023, then increased by 1.41% to 0.3 in 2024, then surged by 162.33% to 0.79 in 2025.
  • Per Business Quant, the three most recent readings for BMY's FCF Payout Ratio are 0.79 (Q4 2025), 0.21 (Q3 2025), and 0.35 (Q2 2025).